Thu, Jan 24, 2019
Indian biotechnology firm Biocon Ltd`s quarterly profit more than doubled, handily beating analysts` estimates, largely driven by strong performance of its biologics businesses.
More >
Wed, Feb 07, 2018
The study of YLB113 was a multinational randomised double-blind controlled trial of 52 weeks duratio
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
